The Upper Merion expansion forms part of a broader $1.2 billion investment by GSK earmarked for advanced manufacturing, artificial intelligence, and digital technologies.
Agree
Disagree
Overview
Debates
Related claims
Topics
Sources
From the article
GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen
Also in
GSK pledges $800M to add biologics production capabilities in Pennsylvania
5
52c7ae14
Article
GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen
0
5
52c7ae14
Article
GSK pledges $800M to add biologics production capabilities in Pennsylvania
0